Education
About Us
Working with TipRanks
Follow Us
Arcutis Biotherapeutics (ARQT)
NASDAQ:ARQT
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 196.54M | $ 59.61M | $ 3.69M | $ 0.00 | $ 0.00 |
| Gross Profit | $ 177.41M | $ 54.62M | $ 2.93M | $ -763.00K | $ -455.00K |
| Operating Income | $ -128.40M | $ -241.10M | $ -301.63M | $ -206.53M | $ -136.65M |
| EBITDA | $ -109.63M | $ -227.43M | $ -294.55M | $ -205.59M | $ -135.22M |
| Net Income | $ -140.04M | $ -262.14M | $ -321.29M | $ -205.90M | $ -135.68M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 227.96M | $ 271.86M | $ 409.59M | $ 387.06M | $ 284.44M |
| Total Assets | $ 348.89M | $ 341.37M | $ 449.27M | $ 408.15M | $ 298.27M |
| Total Debt | $ 3.38M | $ 205.92M | $ 202.54M | $ 77.56M | $ 4.96M |
| Net Debt | $ -67.95M | $ 117.52M | $ 148.90M | $ -18.89M | $ -60.12M |
| Total Liabilities | $ 191.35M | $ 252.70M | $ 239.69M | $ 110.47M | $ 27.65M |
| Stockholders' Equity | $ 157.54M | $ 88.67M | $ 209.58M | $ 297.68M | $ 270.62M |
| Cash Flow | |||||
| Free Cash Flow | $ -112.30M | $ -247.49M | $ -281.00M | $ -175.62M | $ -113.35M |
| Operating Cash Flow | $ -112.16M | $ -247.06M | $ -257.71M | $ -174.63M | $ -113.03M |
| Investing Cash Flow | $ 28.82M | $ 180.23M | $ -87.20M | $ -75.95M | $ -181.82M |
| Financing Cash Flow | $ 66.20M | $ 101.32M | $ 301.80M | $ 281.95M | $ 298.14M |